ID   Calu6/Beta2
AC   CVCL_C8GA
DR   Wikidata; Q123030851
RX   PubMed=19582164;
CC   Population: Caucasian.
CC   Characteristics: Transftected with a IL12RB2/pEGFP-N1 construct (PubMed=19582164).
CC   Transfected with: HGNC; 5972; IL12RB2.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=19582164; DOI=10.1371/journal.pone.0006119;
RA   Airoldi I., Di Carlo E., Cocco C., Caci E., Cilli M., Sorrentino C.,
RA   Sozzi G., Ferrini S., Rosini S., Bertolini G., Truini M., Grossi F.,
RA   Galietta L.J.V., Ribatti D., Pistoia V.;
RT   "IL-12 can target human lung adenocarcinoma cells and normal bronchial
RT   epithelial cells surrounding tumor lesions.";
RL   PLoS ONE 4:E6119-E6119(2009).
//